Prosight Management »

Avantor shares owned by Prosight Management

Quarter-by-quarter ownership of Avantor (AVTR) shares owned by Prosight Management from 13F filings

Historical chart of Prosight Management investment in Avantor

Tip: Access up to 7 years of quarterly data

All positions including Avantor held by Prosight Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avantor by Prosight Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $10M 899k 11.46
2022-09-30 $2.4M 123k 19.60

More positions owned by Prosight Management

Procept Biorobotics Corp (PRCT)
Galapagos Nv Spon Adr (GLPG)
Janux Therapeutics (JANX)
Adc Therapeutics Sa SHS (ADCT)
Kura Oncology (KURA)
Meiragtx Holdings (MGTX)
Nektar Therapeutics Com New (NKTR)
Veeva Sys Cl A Com (VEEV)
Icon SHS (ICLR)
Boston Scientific Corporation (BSX)
Concentra Group Holdings Par Common Stock (CON)
Phreesia (PHR)
Amicus Therapeutics (FOLD)
Select Medical Holdings Corporation (SEM)
Syndax Pharmaceuticals (SNDX)

View all positions for Prosight Management

Top funds holding Avantor

Dodge & Cox
Vanguard Group
BlackRock
Barrow, Hanley, Mewhinney & Strauss
T. Rowe Price Investment Management
Greenhaven Associates
State Street Corporation
Invesco
Clarkston Capital Partners
Dimensional Fund Advisors
New Mountain Capital
London Company
Geode Capital Management
Engine Capital Management
Manufacturers Life Insurance Company

View all funds holding Avantor